China Vaccines Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the China Vaccines market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Vaccines market. Detailed analysis of key players, along with key growth strategies adopted by Vaccines industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • CSL

    • MedImmune LLC

    • Pfizer

    • Tiantan

    • Hissen

    • Novartis(GSK)

    • J&J(Crucell)

    • Kangtai

    • Novartis(CSL)

    • Jintan

    • GSK

    • Sanofi

    • China National Biotec

    • Hualan

    By Type:

    • Live Attenuated Vaccine

    • Inactivated Vaccines

    • Subunit Vaccine

    • Recombinant Vaccines

    • Nucleic Acid Vaccine

    • Other

    By End-User:

    • Children

    • Adults

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Vaccines Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Vaccines Market Size and Growth Rate of Live Attenuated Vaccine from 2016 to 2027

    • 1.3.2 China Vaccines Market Size and Growth Rate of Inactivated Vaccines from 2016 to 2027

    • 1.3.3 China Vaccines Market Size and Growth Rate of Subunit Vaccine from 2016 to 2027

    • 1.3.4 China Vaccines Market Size and Growth Rate of Recombinant Vaccines from 2016 to 2027

    • 1.3.5 China Vaccines Market Size and Growth Rate of Nucleic Acid Vaccine from 2016 to 2027

    • 1.3.6 China Vaccines Market Size and Growth Rate of Other from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Vaccines Market Size and Growth Rate of Children from 2016 to 2027

    • 1.4.2 China Vaccines Market Size and Growth Rate of Adults from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Vaccines Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Vaccines Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Vaccines Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Vaccines Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Vaccines Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Vaccines Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Vaccines Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Vaccines Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Vaccines by Major Types

    • 3.4.1 Market Size and Growth Rate of Live Attenuated Vaccine

    • 3.4.2 Market Size and Growth Rate of Inactivated Vaccines

    • 3.4.3 Market Size and Growth Rate of Subunit Vaccine

    • 3.4.4 Market Size and Growth Rate of Recombinant Vaccines

    • 3.4.5 Market Size and Growth Rate of Nucleic Acid Vaccine

    • 3.4.6 Market Size and Growth Rate of Other

    4 Segmentation of Vaccines Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Vaccines by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Vaccines in Children

    • 4.4.2 Market Size and Growth Rate of Vaccines in Adults

    5 Market Analysis by Regions

    • 5.1 China Vaccines Production Analysis by Regions

    • 5.2 China Vaccines Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Vaccines Landscape Analysis

    • 6.1 North China Vaccines Landscape Analysis by Major Types

    • 6.2 North China Vaccines Landscape Analysis by Major End-Users

    7 Central China Vaccines Landscape Analysis

    • 7.1 Central China Vaccines Landscape Analysis by Major Types

    • 7.2 Central China Vaccines Landscape Analysis by Major End-Users

    8 South China Vaccines Landscape Analysis

    • 8.1 South China Vaccines Landscape Analysis by Major Types

    • 8.2 South China Vaccines Landscape Analysis by Major End-Users

    9 East China Vaccines Landscape Analysis

    • 9.1 East China Vaccines Landscape Analysis by Major Types

    • 9.2 East China Vaccines Landscape Analysis by Major End-Users

    10 Northeast China Vaccines Landscape Analysis

    • 10.1 Northeast China Vaccines Landscape Analysis by Major Types

    • 10.2 Northeast China Vaccines Landscape Analysis by Major End-Users

    11 Southwest China Vaccines Landscape Analysis

    • 11.1 Southwest China Vaccines Landscape Analysis by Major Types

    • 11.2 Southwest China Vaccines Landscape Analysis by Major End-Users

    12 Northwest China Vaccines Landscape Analysis

    • 12.1 Northwest China Vaccines Landscape Analysis by Major Types

    • 12.2 Northwest China Vaccines Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 CSL

      • 13.1.1 CSL Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 MedImmune LLC

      • 13.2.1 MedImmune LLC Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Pfizer

      • 13.3.1 Pfizer Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Tiantan

      • 13.4.1 Tiantan Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Hissen

      • 13.5.1 Hissen Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Novartis(GSK)

      • 13.6.1 Novartis(GSK) Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 J&J(Crucell)

      • 13.7.1 J&J(Crucell) Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 Kangtai

      • 13.8.1 Kangtai Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    • 13.9 Novartis(CSL)

      • 13.9.1 Novartis(CSL) Company Profile and Recent Development

      • 13.9.2 Market Performance

      • 13.9.3 Product and Service Introduction

    • 13.10 Jintan

      • 13.10.1 Jintan Company Profile and Recent Development

      • 13.10.2 Market Performance

      • 13.10.3 Product and Service Introduction

    • 13.11 GSK

      • 13.11.1 GSK Company Profile and Recent Development

      • 13.11.2 Market Performance

      • 13.11.3 Product and Service Introduction

    • 13.12 Sanofi

      • 13.12.1 Sanofi Company Profile and Recent Development

      • 13.12.2 Market Performance

      • 13.12.3 Product and Service Introduction

    • 13.13 China National Biotec

      • 13.13.1 China National Biotec Company Profile and Recent Development

      • 13.13.2 Market Performance

      • 13.13.3 Product and Service Introduction

    • 13.14 Hualan

      • 13.14.1 Hualan Company Profile and Recent Development

      • 13.14.2 Market Performance

      • 13.14.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Vaccines Market Size and Growth Rate of Live Attenuated Vaccine from 2016 to 2027

    • Figure China Vaccines Market Size and Growth Rate of Inactivated Vaccines from 2016 to 2027

    • Figure China Vaccines Market Size and Growth Rate of Subunit Vaccine from 2016 to 2027

    • Figure China Vaccines Market Size and Growth Rate of Recombinant Vaccines from 2016 to 2027

    • Figure China Vaccines Market Size and Growth Rate of Nucleic Acid Vaccine from 2016 to 2027

    • Figure China Vaccines Market Size and Growth Rate of Other from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Vaccines Market Size and Growth Rate of Children from 2016 to 2027

    • Figure China Vaccines Market Size and Growth Rate of Adults from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Vaccines Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Vaccines Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Vaccines Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Vaccines Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Vaccines Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Vaccines Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Vaccines Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Vaccines Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Vaccines

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Vaccines by Different Types from 2016 to 2027

    • Table Consumption Share of Vaccines by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Live Attenuated Vaccine

    • Figure Market Size and Growth Rate of Inactivated Vaccines

    • Figure Market Size and Growth Rate of Subunit Vaccine

    • Figure Market Size and Growth Rate of Recombinant Vaccines

    • Figure Market Size and Growth Rate of Nucleic Acid Vaccine

    • Figure Market Size and Growth Rate of Other

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Vaccines by Different End-Users from 2016 to 2027

    • Table Consumption Share of Vaccines by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Children

    • Figure Market Size and Growth Rate of Adults

    • Table China Vaccines Production by Regions

    • Table China Vaccines Production Share by Regions

    • Figure China Vaccines Production Share by Regions in 2016

    • Figure China Vaccines Production Share by Regions in 2021

    • Figure China Vaccines Production Share by Regions in 2027

    • Table China Vaccines Consumption by Regions

    • Table China Vaccines Consumption Share by Regions

    • Figure China Vaccines Consumption Share by Regions in 2016

    • Figure China Vaccines Consumption Share by Regions in 2021

    • Figure China Vaccines Consumption Share by Regions in 2027

    • Table North China Vaccines Consumption by Types from 2016 to 2027

    • Table North China Vaccines Consumption Share by Types from 2016 to 2027

    • Figure North China Vaccines Consumption Share by Types in 2016

    • Figure North China Vaccines Consumption Share by Types in 2021

    • Figure North China Vaccines Consumption Share by Types in 2027

    • Table North China Vaccines Consumption by End-Users from 2016 to 2027

    • Table North China Vaccines Consumption Share by End-Users from 2016 to 2027

    • Figure North China Vaccines Consumption Share by End-Users in 2016

    • Figure North China Vaccines Consumption Share by End-Users in 2021

    • Figure North China Vaccines Consumption Share by End-Users in 2027

    • Table Central China Vaccines Consumption by Types from 2016 to 2027

    • Table Central China Vaccines Consumption Share by Types from 2016 to 2027

    • Figure Central China Vaccines Consumption Share by Types in 2016

    • Figure Central China Vaccines Consumption Share by Types in 2021

    • Figure Central China Vaccines Consumption Share by Types in 2027

    • Table Central China Vaccines Consumption by End-Users from 2016 to 2027

    • Table Central China Vaccines Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Vaccines Consumption Share by End-Users in 2016

    • Figure Central China Vaccines Consumption Share by End-Users in 2021

    • Figure Central China Vaccines Consumption Share by End-Users in 2027

    • Table South China Vaccines Consumption by Types from 2016 to 2027

    • Table South China Vaccines Consumption Share by Types from 2016 to 2027

    • Figure South China Vaccines Consumption Share by Types in 2016

    • Figure South China Vaccines Consumption Share by Types in 2021

    • Figure South China Vaccines Consumption Share by Types in 2027

    • Table South China Vaccines Consumption by End-Users from 2016 to 2027

    • Table South China Vaccines Consumption Share by End-Users from 2016 to 2027

    • Figure South China Vaccines Consumption Share by End-Users in 2016

    • Figure South China Vaccines Consumption Share by End-Users in 2021

    • Figure South China Vaccines Consumption Share by End-Users in 2027

    • Table East China Vaccines Consumption by Types from 2016 to 2027

    • Table East China Vaccines Consumption Share by Types from 2016 to 2027

    • Figure East China Vaccines Consumption Share by Types in 2016

    • Figure East China Vaccines Consumption Share by Types in 2021

    • Figure East China Vaccines Consumption Share by Types in 2027

    • Table East China Vaccines Consumption by End-Users from 2016 to 2027

    • Table East China Vaccines Consumption Share by End-Users from 2016 to 2027

    • Figure East China Vaccines Consumption Share by End-Users in 2016

    • Figure East China Vaccines Consumption Share by End-Users in 2021

    • Figure East China Vaccines Consumption Share by End-Users in 2027

    • Table Northeast China Vaccines Consumption by Types from 2016 to 2027

    • Table Northeast China Vaccines Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Vaccines Consumption Share by Types in 2016

    • Figure Northeast China Vaccines Consumption Share by Types in 2021

    • Figure Northeast China Vaccines Consumption Share by Types in 2027

    • Table Northeast China Vaccines Consumption by End-Users from 2016 to 2027

    • Table Northeast China Vaccines Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Vaccines Consumption Share by End-Users in 2016

    • Figure Northeast China Vaccines Consumption Share by End-Users in 2021

    • Figure Northeast China Vaccines Consumption Share by End-Users in 2027

    • Table Southwest China Vaccines Consumption by Types from 2016 to 2027

    • Table Southwest China Vaccines Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Vaccines Consumption Share by Types in 2016

    • Figure Southwest China Vaccines Consumption Share by Types in 2021

    • Figure Southwest China Vaccines Consumption Share by Types in 2027

    • Table Southwest China Vaccines Consumption by End-Users from 2016 to 2027

    • Table Southwest China Vaccines Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Vaccines Consumption Share by End-Users in 2016

    • Figure Southwest China Vaccines Consumption Share by End-Users in 2021

    • Figure Southwest China Vaccines Consumption Share by End-Users in 2027

    • Table Northwest China Vaccines Consumption by Types from 2016 to 2027

    • Table Northwest China Vaccines Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Vaccines Consumption Share by Types in 2016

    • Figure Northwest China Vaccines Consumption Share by Types in 2021

    • Figure Northwest China Vaccines Consumption Share by Types in 2027

    • Table Northwest China Vaccines Consumption by End-Users from 2016 to 2027

    • Table Northwest China Vaccines Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Vaccines Consumption Share by End-Users in 2016

    • Figure Northwest China Vaccines Consumption Share by End-Users in 2021

    • Figure Northwest China Vaccines Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of CSL

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CSL

    • Figure Sales and Growth Rate Analysis of CSL

    • Figure Revenue and Market Share Analysis of CSL

    • Table Product and Service Introduction of CSL

    • Table Company Profile and Development Status of MedImmune LLC

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of MedImmune LLC

    • Figure Sales and Growth Rate Analysis of MedImmune LLC

    • Figure Revenue and Market Share Analysis of MedImmune LLC

    • Table Product and Service Introduction of MedImmune LLC

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Tiantan

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Tiantan

    • Figure Sales and Growth Rate Analysis of Tiantan

    • Figure Revenue and Market Share Analysis of Tiantan

    • Table Product and Service Introduction of Tiantan

    • Table Company Profile and Development Status of Hissen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hissen

    • Figure Sales and Growth Rate Analysis of Hissen

    • Figure Revenue and Market Share Analysis of Hissen

    • Table Product and Service Introduction of Hissen

    • Table Company Profile and Development Status of Novartis(GSK)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis(GSK)

    • Figure Sales and Growth Rate Analysis of Novartis(GSK)

    • Figure Revenue and Market Share Analysis of Novartis(GSK)

    • Table Product and Service Introduction of Novartis(GSK)

    • Table Company Profile and Development Status of J&J(Crucell)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of J&J(Crucell)

    • Figure Sales and Growth Rate Analysis of J&J(Crucell)

    • Figure Revenue and Market Share Analysis of J&J(Crucell)

    • Table Product and Service Introduction of J&J(Crucell)

    • Table Company Profile and Development Status of Kangtai

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kangtai

    • Figure Sales and Growth Rate Analysis of Kangtai

    • Figure Revenue and Market Share Analysis of Kangtai

    • Table Product and Service Introduction of Kangtai

    • Table Company Profile and Development Status of Novartis(CSL)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis(CSL)

    • Figure Sales and Growth Rate Analysis of Novartis(CSL)

    • Figure Revenue and Market Share Analysis of Novartis(CSL)

    • Table Product and Service Introduction of Novartis(CSL)

    • Table Company Profile and Development Status of Jintan

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Jintan

    • Figure Sales and Growth Rate Analysis of Jintan

    • Figure Revenue and Market Share Analysis of Jintan

    • Table Product and Service Introduction of Jintan

    • Table Company Profile and Development Status of GSK

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GSK

    • Figure Sales and Growth Rate Analysis of GSK

    • Figure Revenue and Market Share Analysis of GSK

    • Table Product and Service Introduction of GSK

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of China National Biotec

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of China National Biotec

    • Figure Sales and Growth Rate Analysis of China National Biotec

    • Figure Revenue and Market Share Analysis of China National Biotec

    • Table Product and Service Introduction of China National Biotec

    • Table Company Profile and Development Status of Hualan

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hualan

    • Figure Sales and Growth Rate Analysis of Hualan

    • Figure Revenue and Market Share Analysis of Hualan

    • Table Product and Service Introduction of Hualan


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.